Rieke Alten
- Rheumatology top 0.05%
- Immunology top 0.5%
- Hematology top 0.2%
- Genetics top 1%
- Pathology and Forensic Medicine top 1%
- Co-authors
- Thasia WoodworthJoachim SieperAndré BeaulieuJoachim ListingAndrea Rubbert‐RothCésar Ramos-RemusJosef S SmolenEmma Alecock
- Topics
- Rheumatoid Arthritis Research and Therapies (137 papers)Autoimmune and Inflammatory Disorders Research (55 papers)Chronic Lymphocytic Leukemia Research (45 papers)
- Cited by
- RheumatologyHematologyImmunology
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Rieke Alten
210 papers receiving 9.2k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Rheumatology 6.5k
- Immunology 3.3k
- Hematology 2.7k
- Genetics 929
- Pathology and Forensic Medicine 881
Countries citing papers authored by Rieke Alten
This map shows the geographic impact of Rieke Alten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rieke Alten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rieke Alten more than expected).
Fields of papers citing papers by Rieke Alten
This network shows the impact of papers produced by Rieke Alten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rieke Alten. The network helps show where Rieke Alten may publish in the future.
Co-authorship network of co-authors of Rieke Alten
This figure shows the co-authorship network connecting the top 25 collaborators of Rieke Alten. A scholar is included among the top collaborators of Rieke Alten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rieke Alten. Rieke Alten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 5 | |
| 4 | 1 | |
| 5 | 11 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 13 | |
| 9 | 0 | |
| 10 | 10 | |
| 11 | 73 | |
| 12 | 18 | |
| 13 | 7 | |
| 14 | 18 | |
| 15 | 8 | |
| 16 | 6 | |
| 17 | 17 | |
| 18 | 4 | |
| 19 | Safety profile of subcutaneous abatacept focusing On clinically relevant events in patients with rheumatoid arthritis and up to 4.5 years of exposure | 3 |
| 20 | “Flare” and disease worsening in rheumatoid arthritis: Time for a definition | 9 |
About Rieke Alten
Rieke Alten is a scholar working on Rheumatology, Hematology and Genetics, having authored 221 papers that have together received 9.6k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (137 papers), Autoimmune and Inflammatory Disorders Research (55 papers) and Chronic Lymphocytic Leukemia Research (45 papers). The work is most often cited by research in Rheumatology (6.5k citations), Hematology (2.7k citations) and Immunology (3.3k citations). Rieke Alten has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Thasia Woodworth, Joachim Sieper, André Beaulieu, Joachim Listing, Andrea Rubbert‐Roth, César Ramos-Remus, Josef S Smolen, Emma Alecock, J Rovenský and Paul Emery. Their work appears in journals such as New England Journal of Medicine, The Lancet and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.